3079 Stock Overview
Engages in the research and development, design, purchasing/selling, import/export, repair, maintenance and inspection, and rental of medical devices and related peripheral devices in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
DVx Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥913.00 |
| 52 Week High | JP¥1,101.00 |
| 52 Week Low | JP¥877.00 |
| Beta | 0.15 |
| 1 Month Change | -0.76% |
| 3 Month Change | -1.40% |
| 1 Year Change | -13.13% |
| 3 Year Change | -14.27% |
| 5 Year Change | 3.40% |
| Change since IPO | 363.75% |
Recent News & Updates
Shareholder Returns
| 3079 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0.6% | -2.0% | -1.5% |
| 1Y | -13.1% | -9.4% | 13.7% |
Return vs Industry: 3079 underperformed the JP Healthcare industry which returned -9.4% over the past year.
Return vs Market: 3079 underperformed the JP Market which returned 13.7% over the past year.
Price Volatility
| 3079 volatility | |
|---|---|
| 3079 Average Weekly Movement | 2.4% |
| Healthcare Industry Average Movement | 3.3% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 3079 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3079's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 316 | Hiroshi Shibasaki | www.dvx.jp |
DVx Inc. engages in the research and development, design, purchasing/selling, import/export, repair, maintenance and inspection, and rental of medical devices and related peripheral devices in Japan. The company offers arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters; ischemia-related products, that includes RAQUOS and resolution/resolution SD; and EPS Trainer, an intracardiac electrograms simulator; and wonder belt products. The company also engages in the design, manufacture, and purchasing/selling of medical computers; manufacture, purchasing/selling, repair, maintenance and inspection, rental, leasing, and import/export of medicines, quasi drugs, cosmetics, health foods, daily goods, nursing care products, and nursing care equipment; provision of internal and external medical and medical device-related general consulting and services, as well as medical publishing and market research services; and sale and purchase of second hand goods.
DVx Inc. Fundamentals Summary
| 3079 fundamental statistics | |
|---|---|
| Market cap | JP¥8.95b |
| Earnings (TTM) | JP¥54.00m |
| Revenue (TTM) | JP¥47.25b |
165.7x
P/E Ratio0.2x
P/S RatioIs 3079 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3079 income statement (TTM) | |
|---|---|
| Revenue | JP¥47.25b |
| Cost of Revenue | JP¥42.43b |
| Gross Profit | JP¥4.83b |
| Other Expenses | JP¥4.77b |
| Earnings | JP¥54.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 31, 2025
| Earnings per share (EPS) | 5.51 |
| Gross Margin | 10.22% |
| Net Profit Margin | 0.11% |
| Debt/Equity Ratio | 0% |
How did 3079 perform over the long term?
See historical performance and comparisonDividends
5.5%
Current Dividend Yieldn/a
Payout RatioDoes 3079 pay a reliable dividends?
See 3079 dividend history and benchmarks| DVx dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 09 2025 |
| Days until Ex dividend | 96 days |
| Days until Dividend pay date | 169 days |
Does 3079 pay a reliable dividends?
See 3079 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 09:10 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DVx Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kazuaki Hashiguchi | Ichiyoshi Research Institute Inc. |
| Hidekatsu Watanabe | Mizuho Securities Co., Ltd. |
| Katsuhiko Sugiyama | TIW |